KENNETH REED: Open Payments
NPI 1033315437 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 28 payments from 12 companies in 2025. Trend: 2023 $801 · 2024 $611 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $346 |
| ABBVIE INC. | 9 | $174 |
| Boston Scientific Corporation | 2 | $150 |
| Averitas Pharma Inc. | 4 | $67 |
| Spinal Simplicity, LLC | 1 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Bioventus LLC | 1 | $17 |
Products named: INCEPTIV, INTELLIS ADAPTIVESTIM, BOTOX, Intracept, QUTENZA, HA MINUTEMAN G3-R, RELISTOR, Belbuca.
Industry payments across OK — which companies pay providers there.
